Teleflex Incorporated

NYSE (USD): Teleflex Incorporated (TFX)

Last Price

211.25

Today's Change

-0.19 (0.08%)

Day's Change

210.89 - 214.36

Trading Volume

456,449

Overview

Market Cap

9 Billion

Shares Outstanding

47 Million

Avg Volume

476,420

Avg Price (50 Days)

208.05

Avg Price (200 Days)

219.14

PE Ratio

33.75

EPS

6.26

Earnings Announcement

01-Aug-2024

Previous Close

211.44

Open

211.38

Day's Range

210.89 - 213.985

Year Range

177.63 - 262.97

Trading Volume

461,773

Price Change Highlight

1 Day Change

-0.09%

5 Day Change

1.73%

1 Month Change

-1.71%

3 Month Change

-1.63%

6 Month Change

-12.71%

Ytd Change

-15.65%

1 Year Change

-11.51%

3 Year Change

-48.80%

5 Year Change

-36.62%

10 Year Change

96.80%

Max Change

48721.35%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment